Sumoylation of Pdx1 is associated with its nuclear localization and insulin gene activation.

Pancreatic duodenal homeobox-1 (Pdx1) is a transcription factor, and its phosphorylation is thought to be essential for activation of insulin gene expression. This phosphorylation is related to a concomitant shift in molecular mass from 31 to 46 kDa. However, we found that Pdx1 was modified by SUMO-1 (small ubiquitin-related modifier 1) in beta-TC-6 and COS-7 cells, which were transfected with Pdx1 cDNA. This modification contributed to the increase in molecular mass of Pdx1 from 31 to 46 kDa. Additionally, sumoylated Pdx1 localized in the nucleus. The reduction of SUMO-1 protein by use of RNA interference (SUMO-iRNAs) resulted in a significant decrease in Pdx1 protein in the nucleus. A 34-kDa form of Pdx1 was detected by the cells exposed to SUMO-iRNAs in the presence of lactacystin, a proteasome inhibitor. Furthermore, the reduced nuclear sumoylated Pdx1 content was associated with significant lower transcriptional activity of the insulin gene. These findings indicate that SUMO-1 modification is associated with both the localization and stability of Pdx1 as well as its effect on insulin gene activation.

[1]  M. Fujimiya,et al.  Combined expression of pancreatic duodenal homeobox 1 and islet factor 1 induces immature enterocytes to produce insulin. , 2002, Diabetes.

[2]  R. Bernards,et al.  A System for Stable Expression of Short Interfering RNAs in Mammalian Cells , 2002, Science.

[3]  G. Hannon.  RNA interference : RNA , 2002 .

[4]  E. Cerasi,et al.  Regulation of insulin gene transcription , 2002, Diabetologia.

[5]  V. Wilson,et al.  Intracellular targeting of proteins by sumoylation. , 2001, Experimental cell research.

[6]  A. Dejean,et al.  SUMO: of branched proteins and nuclear bodies , 2001, Oncogene.

[7]  C. Mayhew,et al.  Regulation of Heat Shock Transcription Factor 1 by Stress-induced SUMO-1 Modification* , 2001, The Journal of Biological Chemistry.

[8]  K. Docherty,et al.  Phosphorylation-dependent nucleocytoplasmic shuttling of pancreatic duodenal homeobox-1. , 2001, Diabetes.

[9]  M. Fujimiya,et al.  Differentiation of immature enterocytes into enteroendocrine cells by Pdx1 overexpression. , 2001, American journal of physiology. Gastrointestinal and liver physiology.

[10]  T. Tuschl,et al.  Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells , 2001, Nature.

[11]  Jie Zhou,et al.  Glucagon-Like Peptide-1 Causes Pancreatic Duodenal Homeobox-1 Protein Translocation from the Cytoplasm to the Nucleus of Pancreatic β-Cells by a Cyclic Adenosine Monophosphate/Protein Kinase A-Dependent Mechanism. , 2001, Endocrinology.

[12]  R. Hay,et al.  SUMO-1 Conjugation in Vivo Requires Both a Consensus Modification Motif and Nuclear Targeting* , 2001, The Journal of Biological Chemistry.

[13]  R. Arai,et al.  Insulin production in a neuroectodermal tumor that expresses islet factor-1, but not pancreatic-duodenal homeobox 1. , 2001, The Journal of clinical endocrinology and metabolism.

[14]  F. Melchior,et al.  SUMO--nonclassical ubiquitin. , 2000, Annual review of cell and developmental biology.

[15]  G. Rutter,et al.  Glucose-stimulated Preproinsulin Gene Expression and Nucleartrans-Location of Pancreatic Duodenum Homeobox-1 Require Activation of Phosphatidylinositol 3-Kinase but Not p38 MAPK/SAPK2* , 2000, The Journal of Biological Chemistry.

[16]  A. Dejean,et al.  c-Jun and p53 Activity Is Modulated by SUMO-1 Modification* , 2000, The Journal of Biological Chemistry.

[17]  E. Yeh,et al.  Ubiquitin-like proteins: new wines in new bottles. , 2000, Gene.

[18]  L. Bouwens,et al.  Adult human pancreatic duct and islet cells exhibit similarities in expression and differences in phosphorylation and complex formation of the homeodomain protein Ipf-1. , 2000, Diabetes.

[19]  Phillip D. Zamore,et al.  RNA Interference , 2000, Science.

[20]  H. Saitoh,et al.  Functional Heterogeneity of Small Ubiquitin-related Protein Modifiers SUMO-1 versus SUMO-2/3* , 2000, The Journal of Biological Chemistry.

[21]  N. Wong,et al.  Transforming growth factor beta induction of insulin gene expression is mediated by pancreatic and duodenal homeobox gene-1 in rat insulinoma cells. , 2000, European journal of biochemistry.

[22]  K. Docherty,et al.  Insulin stimulates pancreatic-duodenal homoeobox factor-1 (PDX1) DNA-binding activity and insulin promoter activity in pancreatic beta cells. , 1999, The Biochemical journal.

[23]  P. Berggren,et al.  Identification of a nuclear localization signal, RRMKWKK, in the homeodomain transcription factor PDX‐1 , 1999, FEBS letters.

[24]  A. Hengstermann,et al.  Activation of p53 by conjugation to the ubiquitin‐like protein SUMO‐1 , 1999, The EMBO journal.

[25]  R. Hay,et al.  SUMO‐1 modification activates the transcriptional response of p53 , 1999, The EMBO journal.

[26]  M. Fujimiya,et al.  Transcription factors and age-related decline in apolipoprotein A-I expression. , 1999, Journal of lipid research.

[27]  R. Walther,et al.  The nuclear localization signal (NLS) of PDX-1 is part of the homeodomain and represents a novel type of NLS. , 1999, European journal of biochemistry.

[28]  J. Olefsky,et al.  Membrane-targeted Phosphatidylinositol 3-Kinase Mimics Insulin Actions and Induces a State of Cellular Insulin Resistance* , 1999, The Journal of Biological Chemistry.

[29]  R. Hay,et al.  Identification of the Enzyme Required for Activation of the Small Ubiquitin-like Protein SUMO-1* , 1999, The Journal of Biological Chemistry.

[30]  K. Docherty,et al.  Glucose Stimulates Translocation of the Homeodomain Transcription Factor PDX1 from the Cytoplasm to the Nucleus in Pancreatic β-Cells* , 1999, The Journal of Biological Chemistry.

[31]  J. Egan,et al.  Glucagon-like peptide-1 regulates the beta cell transcription factor, PDX-1, in insulinoma cells. , 1999, Endocrinology.

[32]  Aaron Ciechanover,et al.  The ubiquitin–proteasome pathway: on protein death and cell life , 1998, The EMBO journal.

[33]  R. Hay,et al.  SUMO-1 modification of IkappaBalpha inhibits NF-kappaB activation. , 1998, Molecular cell.

[34]  F. Melchior,et al.  Molecular Characterization of the SUMO-1 Modification of RanGAP1 and Its Role in Nuclear Envelope Association , 1998, The Journal of cell biology.

[35]  C. Pickart.  Targeting of substrates to the 26S proteasome , 1997, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[36]  G. Blobel,et al.  The ubiquitin‐like protein Smt3p is activated for conjugation to other proteins by an Aos1p/Uba2p heterodimer , 1997, The EMBO journal.

[37]  E. Yeh,et al.  Preferential Modification of Nuclear Proteins by a Novel Ubiquitin-like Molecule* , 1997, The Journal of Biological Chemistry.

[38]  M. Carty,et al.  Identification of cis- and trans-Active Factors Regulating Human Islet Amyloid Polypeptide Gene Expression in Pancreatic β-Cells* , 1997, The Journal of Biological Chemistry.

[39]  M. Dasso,et al.  RanBP2 associates with Ubc9p and a modified form of RanGAP1. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[40]  A. Pizzuti,et al.  SMT3A, a human homologue of the S. cerevisiae SMT3 gene, maps to chromosome 21qter and defines a novel gene family. , 1997, Genomics.

[41]  F. Melchior,et al.  A Small Ubiquitin-Related Polypeptide Involved in Targeting RanGAP1 to Nuclear Pore Complex Protein RanBP2 , 1997, Cell.

[42]  William L. Clarke,et al.  Pancreatic agenesis attributable to a single nucleotide deletion in the human IPF1 gene coding sequence , 1997, Nature Genetics.

[43]  H. Kaneto,et al.  Glycation-dependent, reactive oxygen species-mediated suppression of the insulin gene promoter activity in HIT cells. , 1997, The Journal of clinical investigation.

[44]  G. Blobel,et al.  A novel ubiquitin-like modification modulates the partitioning of the Ran-GTPase-activating protein RanGAP1 between the cytosol and the nuclear pore complex , 1996, The Journal of cell biology.

[45]  Y. Matsuzawa,et al.  PDX-1 Induces Insulin and Glucokinase Gene Expressions in αTC1 Clone 6 Cells in the Presence of Betacellulin , 1996, Diabetes.

[46]  G. Waeber,et al.  Transcriptional activation of the GLUT2 gene by the IPF-1/STF-1/IDX-1 homeobox factor. , 1996, Molecular endocrinology.

[47]  B. Hogan,et al.  PDX-1 is required for pancreatic outgrowth and differentiation of the rostral duodenum. , 1996, Development.

[48]  O. Madsen,et al.  The homeodomain protein IPF-1/STF-1 is expressed in a subset of islet cells and promotes rat insulin 1 gene expression dependent on an intact E1 helix-loop-helix factor binding site. , 1995, The Biochemical journal.

[49]  O. Madsen,et al.  Transcriptional regulation of the human insulin gene is dependent on the homeodomain protein STF1/IPF1 acting through the CT boxes. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[50]  H. Edlund,et al.  Insulin-promoter-factor 1 is required for pancreas development in mice , 1994, Nature.

[51]  J. Habener,et al.  IDX‐1: a new homeodomain transcription factor expressed in rat pancreatic islets and duodenum that transactivates the somatostatin gene. , 1994, The EMBO journal.

[52]  H. Ohlsson,et al.  IPF1, a homeodomain‐containing transactivator of the insulin gene. , 1993, The EMBO journal.